NCT05082142View on ClinicalTrials.gov

Tranexamic Acid to Improve Same-day Discharge Rates After Holmium Laser Enucleation of the Prostate (HoLEP)

PHASE4CompletedINTERVENTIONAL

Enrollment

110

Participants

Timeline

Start Date

September 17, 2021

Primary Completion Date

June 15, 2022

Study Completion Date

December 14, 2022

Conditions

Kidney CalculiUrologic DiseasesBenign Prostatic Hypertrophy

Interventions

DRUG

Tranexamic acid

Patients in the intervention arm will receive 1g of intraoperative IV TXA during the HoLEP procedure.

Trial Locations (1)

60611

Northwestern University, Chicago

All Listed Sponsors

lead

Northwestern University

OTHER

NCT05082142 - Tranexamic Acid to Improve Same-day Discharge Rates After Holmium Laser Enucleation of the Prostate (HoLEP) | Biotech Hunter | Biotech Hunter